Hiba Zahi, Abdelmoughit Hosni, Zaynab Iraqi Houssaini, Hounaida Jerguigue, Rachida Latib, Youssef Omor
Radiology Department, National Institute of Oncology, Ibn Sina Hospital, Mohammed V University, Rabat, Morocco.
Radiol Case Rep. 2022 Aug 17;17(10):3979-3981. doi: 10.1016/j.radcr.2022.07.083. eCollection 2022 Oct.
Immune check point inhibitor has made far-reaching changes in the management of lung adenocarcinoma improving drastically the prognosis. We present a case of a 50 years old women beneficiary of pembrolizumab who has suffered an acute pneumonitis diagnosed with CT imaging the days following the initiation of the drug. The occurrence of immune-related events such as pneumonitis complicates the use of immunotherapy and requires a well verse radiologist in the matter to diagnosis and helps prevent further aggravation.
免疫检查点抑制剂在肺腺癌的治疗管理方面带来了深远变革，极大地改善了预后。我们报告一例50岁女性患者，她是帕博利珠单抗的受益者，在开始使用该药物几天后，经CT成像诊断出患有急性肺炎。免疫相关事件如肺炎的发生使免疫治疗的应用变得复杂，这需要在该领域经验丰富的放射科医生进行诊断，并有助于防止病情进一步加重。
